153 -6 (80) 2025 - Sadulloyeva R.S., Mirzoyeva M.R. - LEVEL OF KNOWLEDGE OF THE GLOBAL SPREAD OF COVID-19 DISEASE

LEVEL OF KNOWLEDGE OF THE GLOBAL SPREAD OF COVID-19 DISEASE

Sadulloyeva R.S. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Mirzoyeva M.R. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

On January 30, 2020, the World Health Organization (WHO) declared the coronavirus outbreak in China a public health emergency of international concern. WHO Director-General Tedros Adhanom Ghebreyesus said after an emergency committee meeting in Geneva, “I am declaring an international public health emergency due to the global coronavirus outbreak.” The etiology and pathogenesis of coronavirus infection are described. The etiology and pathogenesis of coronavirus infection are described. Clinical manifestations and risk factors for this infection are noted. A review of the literature on the current situation in the world was conducted.

Key words: incidence of COVID-19; incidence of SARSCoV-2; Etiology of COVID-19; Pathogenesis of COVID-19; Coronavirus pandemic; clinical manifestations of coronavirus infection; situation in the world.

First page

786

Last page

789

For citation:Sadulloyeva R.S., Mirzoyeva M.R. - LEVEL OF KNOWLEDGE OF THE GLOBAL SPREAD OF COVID-19 DISEASE //New Day in Medicine 6(80)2025 786-789 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

  1. World Health Organization. Novel Coronavirus (2019-nCoV) situation reports. https://www.worldometers.info/coronavirus/ Accessed: 28 Sept. 2021.
  2. Oblokulov A.R., Musaeva D.M., Elmuradova A.A. (2020) Clinical and epidemiological characteristics of the new coronavirus infection (COVID-19). // New Day in Medicine. №2 (30/2) p.110-115.
  3. Bikdeli B, Madhavan MV, Jimenez D et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up. JACC. 2020. doi:10.1016/j.jacc.2020.04.031.
  4. Cao Y., Liu X., Xiong L. et al. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J. Med. Virol., 2020; doi: 10.1002/jmv.25 822.
  5. Iba T., Levy J.H., Levi M. и соавт.: Coagulopathy of coronavirus disease 2019. Crit. Care Med., 2020; doi: 10.1097/CCM.0 000 000 000 004 458.
  6. Levi M., Thachil J., Iba T., Levye J.H.: Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020; 7: e438–e440.
  7. Wang D, Hu B, Hu C et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020.
  8. Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet.2020;395:507-513.
  9. Han H, Yang L, Liu R et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med.2020;58:1116-1120.
  10. Tao J, Song Z, Yang L. et al. Emergency management for preventing and controlling nosocomial infection of 2019 novel coronavirus: implications for the dermatology department. Br J Dermatol. 2020;182:1477-1478.
  11. Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.
  12. Huan H., Lan Y., Liu R., et al. Prominent changes in blood coagulation of patients with SARS-Cov2 infection. Clin Chem Lab Med. 2020; 58(7): 1116–1120. DOI: 10/1515/cclm-2020-0188.

    file

    download